Clinical trials driven by IoT

Clinical trials are an essential but costly component of drug development. It typically takes pharmaceutical companies 17 years to get from basic science to clinical product.³ With connected devices, clinical trials can benefit from digital health technology with significant cost reductions of conducting clinical trials, as well as potentially leading to safer outcomes for patients involved in them.

IoT can help make the clinical trials more effective, by rapidly providing deep levels of insight into the success of therapies — and potentially enabling ineffective trials to be cancelled quicker.

References

^{3 https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-life-sciences-outlook.pdf
↩}